Conformia sells intellectual property to Oracle, disbands
Conformia Software, maker of software used to manage software cycles end-to-end, has sold its intellectual property assets to Oracle for an undisclosed amount. The company, which specialized in drug development processes, appears to now be defunct. Redwood Shores, Calif.-based Oracle, on the other hand, plans to merge this technology with its existing Oracle Agile Product Lifecycle Management product, which also assists and monitors drug development from beginning to commercialization.
Conformia previously raised $34 million in capital from Foundation Capital, Mentor Capital Group, Jafco Ventures, NextLevel Venture Partners, SAP AG, Sequoia Capital, Stanford Univeristy, WS Investment and Capital Investors.
Next Story: Sega appoints new execs, aligns Western markets
Previous Story: Gydget buy pays off for Adgregate in new product rollout
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.